<DOC>
	<DOC>NCT00489866</DOC>
	<brief_summary>The proposed investigation will determine the therapeutic potential of aripiprazole augmentation to a stable antidepressant regimen for reducing posttraumatic stress disorder (PTSD) symptoms, cognitive symptoms, psychotic symptoms, and depressive symptoms in veterans with PTSD.</brief_summary>
	<brief_title>Aripiprazole Augmentation of Antidepressants in PTSD</brief_title>
	<detailed_description />
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Outpatient veterans with posttraumatic stress disorder (PTSD) Receiving treatment with an antidepressant at a stable dose for 4 weeks Male or female Ages 1865 years old</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>PTSD</keyword>
	<keyword>Antidepressant</keyword>
	<keyword>Aripiprazole</keyword>
	<keyword>OEF</keyword>
	<keyword>OIF</keyword>
</DOC>